Form 4 Filing: Izzar Rachid Acquires (Grant) shares of $BIIB

STOCK AWARD / GRANT

⚡ MATERIALITY: 1/10

corporate issuer

BIOGEN INC.

Ticker: $BIIB

Transaction Value

N/A (Non-Open-Market)

Price/Share: $0.00 (Non-Open-Market)

transaction date

2026-02-13

Shares: 7,390

Market Price Activity

HillSignal AI Analytical Report

SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Izzar Rachid, holds the title of Head of Global Product Strat. at BIOGEN INC..

On 2026-02-13, the insider transacted 7,390 shares.This transaction is a non-open-market event (such as a stock grant or option exercise) with a reported price per share of $0.00.

Executive Summary Summary

Izzar Rachid (Head of Global Product Strat.) was granted $0 of $BIIB

Post-Transaction Position: 7,390 shares

SEC Accession No: 0000875045-26-000030 (CIK: 1875506)

Verified Multi-Source Index

Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.

SEC EDGAR FilingView Source Form 4

Yahoo Finance$BIIB Quote & Profile

OpenCorporates RegistryVerify Corporate Identity

Google News$BIIB News Coverage